Skip to main content
. 2013 Dec 3;175(1):25–31. doi: 10.1111/cei.12198

Figure 2.

Figure 2

Measurement of PU.1, interleukin (IL)-9 and vascular endothelial growth factor (VEGF) mRNA levels in peripheral blood mononuclear cells (PBMCs) and skin samples by real-time reverse transcription–polymerase chain reaction (RT–PCR). The expression of PU.1 and IL-9 mRNA levels in PBMCs as well as IL-9 and VEGF mRNA levels in skin samples were all elevated significantly in atopic dermatitis (AD) patients (*P < 0·01). Pso: psoriasis; HC: healthy controls.